checkpoint inhibitors advance standard of care for non-small cell lung cancers
Published 4 years ago • 214 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
5:53
targeted therapy in non-small cell lung cancer
-
12:33
introduction: checkpoint inhibition in non-small cell lung cancer
-
3:46
understanding immunotherapy for lung cancer
-
8:16
immune checkpoint inhibitor combinations in non-small cell lung cancer
-
37:23
driver mutation lung cancer
-
44:56
immune checkpoint blockade in cancer therapy
-
1:00:52
immunotherapy for lung cancer: what patients need to know, with julie brahmer
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
7:42
immune checkpoint inhibitors in squamous non-small cell lung cancer
-
4:56
immunotherapy for previously treated advanced non-small cell lung cancer
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
2:54
best results ever in the treatment of small cell lung cancer: immunotherapy in primary care
-
6:02
checkpoint inhibitors in locally advanced nsclc
-
0:56
checkpoint inhibitors for lung cancer treatment
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
27:43
targeting the immune system with checkpoint inhibitors
-
1:19
immune checkpoint inhibitors, durvalumab plus tremelimumab, for non-small cell lung cancer
-
4:36
efficacy and safety of checkpoint inhibitors in lung cancer
-
8:00
immunotherapy for squamous non-small cell lung cancer
-
1:13
a new standard of care for advanced lung cancer: what’s next for pembrolizumab?
-
52:27
immunotherapy/checkpoint inhibitor, targeted immunotherapy drugs 5/2/18